Clinical trial
Phase II Study of 5-azacytidine and Lintuzumab in Myelodysplastic Syndromes (MDS)
NCT00997243 is registered in ClinicalTrials.gov with Alison Walker as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Study of 5-azacytidine and Lintuzumab in Myelodysplastic Syndromes (MDS)
- Lead sponsor
- Alison Walker
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- November 30, 2009
- Completion date
- May 31, 2011
- Enrollment
- 7 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.